H2S activated self-assembly gold-DNA nanomachine for enhanced tumor fluorescence imaging and phototherapy - Details

author：

Indexed by：

Scopus

Abstract：

The　development　of　efficient　photosensitizer　agents　is　crucial　for　cancer　phototherapy.　However,　conventional　photosensitizers　often　suffer　from　low　tumor　selectivity　and　poor　retention　in　tumor,　while　single-modal　therapies　such　as　photodynamic　therapy　(PDT)　or　photothermal　therapy　(PTT)　often　exhibit　diminished　efficacy.　Herein,　we　have　developed　a　H2S　activated　gold　nanoparticle　(AuNPs)-DNA　nanomachine　for　tumor　targeting,　fluorescence　imaging　and　combination　therapy　using　PDT　and　PTT.　The　nanomachine　consists　of　G-quadruplex　AS1411　aptamer　(serving　as　both　a　targeting　ligand　and　a　carrier　for　the　photosensitizer,　Ce6)　and　AuNPs　(serving　as　a　DNA　carrier　and　PTT　agent　after　response　to　H2S).　Upon　activation　by　H2S,　which　is　overexpressed　in　tumors,　the　system　releases　AS1411-Ce6　and　causes　aggregation　of　AuNPs,　resulting　in　an　absorbance　red　shift　to　the　near-infrared　(NIR)　region.　Upon　laser　irradiation,　the　released　AS1411-Ce6　generated　reactive　oxygen　species　for　PDT　(using　a　660　nm　laser),　while　the　aggregated　AuNPs　enhanced　the　PTT　effect　(using　an　808　nm　laser).　Both　in　vitro　and　in　vivo　experiments　demonstrated　that　this　dual-modal　phototherapy　significantly　inhibited　tumor　growth.　Therefore,　the　tumor　microenvironment　biomarker　responsive　nanomachine　represents　a　promising　nanoplatform　for　combinatorial　tumor　therapy.　©　2025　Elsevier　B.V.

Keyword：

Aggregation AS1411 Gold nanoparticles H2S Phototherapy

Community：

[ 1 ] [Li H.]Liver Disease Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China
[ 2 ] [Li H.]The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350007, China
[ 3 ] [Li H.]College of Biological Science and Engineering, Fuzhou University, Fuzhou, 350116, China
[ 4 ] [Li W.]Liver Disease Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China
[ 5 ] [Li W.]The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350007, China
[ 6 ] [Li W.]College of Biological Science and Engineering, Fuzhou University, Fuzhou, 350116, China
[ 7 ] [Zheng C.]College of Chemistry, Fuzhou University, Fuzhou, 350116, China
[ 8 ] [Ding L.]The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350007, China
[ 9 ] [Ding L.]School of Rare Earths, University of Science and Technology of China, Hefei, 230026, China
[ 10 ] [Ke J.]The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350007, China
[ 11 ] [Ke J.]School of Rare Earths, University of Science and Technology of China, Hefei, 230026, China
[ 12 ] [Wu M.]The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350007, China
[ 13 ] [Wu M.]College of Biological Science and Engineering, Fuzhou University, Fuzhou, 350116, China
[ 14 ] [Liu X.]The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350007, China
[ 15 ] [Liu X.]College of Biological Science and Engineering, Fuzhou University, Fuzhou, 350116, China
[ 16 ] [Zhang X.]Liver Disease Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China
[ 17 ] [Zhang X.]The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350007, China
[ 18 ] [Zhang X.]College of Biological Science and Engineering, Fuzhou University, Fuzhou, 350116, China
[ 19 ] [Zeng Y.]Liver Disease Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China
[ 20 ] [Zeng Y.]The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350007, China
[ 21 ] [Zeng Y.]College of Biological Science and Engineering, Fuzhou University, Fuzhou, 350116, China

Reprint 's Address：

Email：

Show more details

Related Keywords：

H2S activated self-assembly gold-DNA nanomachine for enhanced tumor fluorescence imaging and phototherapy
2025，SENSORS AND ACTUATORS B-CHEMICAL
Target-triggered aggregation of gold nanoparticles for photothermal quantitative detection of adenosine using a thermometer as readout
2020，ANALYTICA CHIMICA ACTA
Dark field microscope-based single nanoparticle identification coupled with statistical analysis for ultrasensitive biotoxin detection in complex sample matrix
2020，MICROCHIMICA ACTA
Long-Lived Room-Temperature Phosphorescence Based on Hydrogen Bonding Self-Assembling Supramolecular Film
2021，CHINESE JOURNAL OF CHEMISTRY
A Single-Chain Variable Fragment Antibody Inhibits Aggregation of Phosphorylated Tau and Ameliorates Tau Toxicity in vitro and in vivo
2021，JOURNAL OF ALZHEIMERS DISEASE

Source ：

Sensors and Actuators B: Chemical

ISSN： 0925-4005

Year： 2025

Volume： 436

6 . 3 9 3

JCR@2018

Cited Count：

WoS CC Cited Count：

SCOPUS Cited Count：

ESI Highly Cited Papers on the List： 0 Unfold All

WanFang Cited Count：

Chinese Cited Count：

30 Days PV： 1

Affiliated Colleges：

Get Fulltext

DOI Library Discovery Baidu Scholar Search SCOPUS

Type
Departments

All Years Choose Year From to